These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9506737)

  • 1. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels.
    Eberhart GP; Mendez AJ; Freeman MW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):836-46. PubMed ID: 9506737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.
    Remaley AT; Schumacher UK; Stonik JA; Farsi BD; Nazih H; Brewer HB
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1813-21. PubMed ID: 9327782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.
    Walter M; Gerdes U; Seedorf U; Assmann G
    Biochem Biophys Res Commun; 1994 Nov; 205(1):850-6. PubMed ID: 7999122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.
    Walter M; Reinecke H; Gerdes U; Nofer JR; Höbbel G; Seedorf U; Assmann G
    J Clin Invest; 1996 Nov; 98(10):2315-23. PubMed ID: 8941649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
    Marcil M; Yu L; Krimbou L; Boucher B; Oram JF; Cohn JS; Genest J
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):159-69. PubMed ID: 9888879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
    Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
    J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
    Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
    Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?
    Alenezi MY; Marcil M; Blank D; Sherman M; Genest J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):761-4. PubMed ID: 14764793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas.
    Schuler-Lüttmann S; Zhu Y; Hoffmann M; März W; Feussner G; Wieland H; Assmann G; von Eckardstein A
    Metabolism; 2000 Jun; 49(6):770-7. PubMed ID: 10877205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients.
    Rogler G; Trümbach B; Klima B; Lackner KJ; Schmitz G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):683-90. PubMed ID: 7749882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
    Dullaart RP; Groen AK; Dallinga-Thie GM; de Vries R; Sluiter WJ; van Tol A
    Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells.
    Oram JF; Mendez AJ; Lymp J; Kavanagh TJ; Halbert CL
    J Lipid Res; 1999 Oct; 40(10):1769-81. PubMed ID: 10508196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I.
    von Eckardstein A; Chirazi A; Schuler-Lüttmann S; Walter M; Kastelein JJ; Geisel J; Real JT; Miccoli R; Noseda G; Höbbel G; Assmann G
    J Lipid Res; 1998 May; 39(5):987-98. PubMed ID: 9610765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts.
    Haidar B; Mott S; Boucher B; Lee CY; Marcil M; Genest J
    J Lipid Res; 2001 Feb; 42(2):249-57. PubMed ID: 11181755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.
    Nofer JR; Fobker M; Höbbel G; Voss R; Wolinska I; Tepel M; Zidek W; Junker R; Seedorf U; von Eckardstein A; Assmann G; Walter M
    Biochemistry; 2000 Dec; 39(49):15199-207. PubMed ID: 11106499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.